Skip to content

Evaluation of blood biochemical indices for early neurological deterioration in patients with ischemic stroke

Evaluation of blood biochemical indices for early neurological deterioration in patients with ischemic stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056158
Enrollment
Unknown
Registered
2022-02-01
Start date
2022-01-24
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke

Interventions

Case series:None

Sponsors

The Second Affiliated Hospital of Shantou University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.The diagnosis of ischemic stroke is in line with the "Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke in China 2018" issued by the Cerebrovascular Disease Group of the Neurology Branch of the Chinese Medical Association in 2018; 2.Neuroimaging shows ischemic lesions in patients; 3.Patients were admitted within 24 hours of onset of illness.

Exclusion criteria

Exclusion criteria: 1.Patients with incomplete clinical data (lack of peripheral blood collection, imaging data, hospital stay of less than 72 hours). 2.Patients have a history of rheumatism-related diseases, hematologic diseases, severe liver and kidney failure, psychiatric diseases, head trauma or surgery, and tumor diseases.

Design outcomes

Primary

MeasureTime frame
Blood biochemical indicators;

Countries

China

Contacts

Public ContactWei Chen

The Second Affiliated Hospital of Shantou University Medical School

chw7203@126.com+86 13829662533

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026